Earnings

Phathom Pharmaceuticals is demonstrating remarkable momentum in the market, fueled by unexpectedly robust quarterly earnings and significant clinical development milestones....

Rafael's stock is experiencing a severe downturn, driven by a combination of technical breakdowns, disappointing quarterly results, and intense selling...

In a surprising market reaction, Energous Corporation witnessed its stock decline following the announcement of what should have been celebratory...

Fuel Tech Inc. witnessed a dramatic after-hours selloff, with its stock price collapsing by 15.87% in response to its third-quarter...

Friday's trading session delivered a severe blow to Oxford Lane Capital shareholders as the stock plummeted to a fresh 52-week...

Biotechnology firm Ocugen Inc. finds itself navigating a critical juncture. While the company's latest earnings report revealed substantial revenue growth,...

The financial technology powerhouse Fiserv is confronting its most severe operational challenge in decades. A devastating earnings collapse in late...

Eli Lilly and Company has positioned itself for substantial expansion through a series of strategic developments announced in early November...

The biotechnology firm Lyra Therapeutics Inc finds itself navigating turbulent waters, with its equity valuation under severe pressure. A combination...

Recent quarterly disclosures reveal a company grappling with persistent financial challenges. Advanced Oxygen Technologies continues to operate at a deficit,...